Wang, S.; Xie, D.; Yue, H.; Li, G.; Jiang, B.; Gao, Y.; Zheng, Z.; Zheng, X.; Wu, G.
Phospholipase C Beta 2 as a Key Regulator of Tumor Progression and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Renal Cell Carcinoma. Biomedicines 2025, 13, 304.
https://doi.org/10.3390/biomedicines13020304
AMA Style
Wang S, Xie D, Yue H, Li G, Jiang B, Gao Y, Zheng Z, Zheng X, Wu G.
Phospholipase C Beta 2 as a Key Regulator of Tumor Progression and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Renal Cell Carcinoma. Biomedicines. 2025; 13(2):304.
https://doi.org/10.3390/biomedicines13020304
Chicago/Turabian Style
Wang, Shijin, Deqian Xie, Hongzhe Yue, Guandu Li, Bowen Jiang, Yaru Gao, Zunwen Zheng, Xu Zheng, and Guangzhen Wu.
2025. "Phospholipase C Beta 2 as a Key Regulator of Tumor Progression and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Renal Cell Carcinoma" Biomedicines 13, no. 2: 304.
https://doi.org/10.3390/biomedicines13020304
APA Style
Wang, S., Xie, D., Yue, H., Li, G., Jiang, B., Gao, Y., Zheng, Z., Zheng, X., & Wu, G.
(2025). Phospholipase C Beta 2 as a Key Regulator of Tumor Progression and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Renal Cell Carcinoma. Biomedicines, 13(2), 304.
https://doi.org/10.3390/biomedicines13020304